Current Infectious Disease Reports

, Volume 9, Issue 4, pp 308–314 | Cite as

Neurocritical care of patients with central nervous system infections

Article

Abstract

Bacterial meningitis and viral encephalitis are life-threatening infections with high mortality rates. Patients who survive these infections often remain permanently disabled. Potential neurologic complications requiring careful attention include impaired consciousness, elevated intracranial pressure, hydrocephalus, stroke, and seizures. Systemic complications are also common and are frequently the immediate cause of death. Critical care of these patients should focus not only on treatment of the underlying infection and its immediate complications but also on minimizing secondary brain injury. Given the increasing complexity of the diagnostic and therapeutic modalities available in managing central nervous system infections, the involvement of neurocritical care units and neurointensivists may be particularly helpful in improving outcomes.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    van de Beek D, de Gans J, Spanjaard L, et al.: Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 2004, 351:1849–1859.PubMedCrossRefGoogle Scholar
  2. 2.
    Weisfelt M, van de Beek D, Spanjaard L, et al.: Clinical features, complications, and outcome in adults with pneumococcal meningitis: a prospective case series. Lancet Neurol 2006, 5:123–129.PubMedCrossRefGoogle Scholar
  3. 3.
    van de Beek D, Schmand B, de Gans J, et al.: Cognitive impairment in adults with good recovery after bacterial meningitis. J Infect Dis 2002, 186:1047–1052.PubMedCrossRefGoogle Scholar
  4. 4.
    Whitley RJ, Alford CA, Hirsch MS, et al.: Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med 1986, 314:144–149.PubMedCrossRefGoogle Scholar
  5. 5.
    Raschilas F, Wolff M, Delatour F, et al.: Outcome of and prognostic factors for herpes simplex encephalitis in adult patients. Clin Infect Dis 2002, 35:254–260.PubMedCrossRefGoogle Scholar
  6. 6.
    Pepperell C, Rau N, Krajden S, et al.: West Nile virus infection in 2002: morbidity and mortality among patients admitted to hospital in southcentral Ontario. CMAJ 2003, 168:1399–1405.PubMedGoogle Scholar
  7. 7.
    Menon D: Neurocritical care: turf label, organizational construct, or clinical asset? Curr Opin Crit Care 2004, 10:91–93.PubMedCrossRefGoogle Scholar
  8. 8.
    Flores-Cordero JM, Amaya-Villar R, Rincon-Ferrari MD, et al.: Acute community-acquired bacterial meningitis in adults admitted to the intensive care unit: clinical manifestations, management and prognostic factors. Intensive Care Med 2003, 29:1967–1973.PubMedCrossRefGoogle Scholar
  9. 9.
    Kennedy PG: A retrospective analysis of forty-six cases of herpes simplex encephalitis in Glasgow between 1962 and 1985. Q J Med 1988, 68:533–540.PubMedGoogle Scholar
  10. 10.
    Auburtin M, Porcher R, Bruneel F, et al.: Pneumococcal meningitis in the intensive care unit: prognostic factors of clinical outcome in a series of 80 patients. Am J Respir Crit Care Med 2002, 165:713–717.PubMedGoogle Scholar
  11. 11.
    Tunkel AR, Scheld WM: Acute meningitis. In Principles and Practice of Infectious Diseases. Edited by Mandell GL, Bennett JE, Dolin R. Philadelphia: Elsevier; 2005:1083–1126.Google Scholar
  12. 12.
    Whitley RJ, Gnann JW: Viral encephalitis: familiar infections and emerging pathogens. Lancet 2002, 359:507–513.PubMedCrossRefGoogle Scholar
  13. 13.
    Lindvall P, Ahlm C, Ericsson M, et al.: Reducing intracranial pressure may increase survival among patients with bacterial meningitis. Clin Infect Dis 2004, 38:384–390.PubMedCrossRefGoogle Scholar
  14. 14.
    Barnett GH, Ropper AH, Romeo J: Intracranial pressure and outcome in adult encephalitis. J Neurosurg 1988, 68:585–588.PubMedGoogle Scholar
  15. 15.
    Solomon T, Dung NM, Kneen R, et al.: Seizures and raised intracranial pressure in Vietnamese patients with Japanese encephalitis virus. Brain 2002, 125:1084–1093.PubMedCrossRefGoogle Scholar
  16. 16.
    Wang KW, Chang WN, Chang HW, et al.: Clinical relevance of hydrocephalus in bacterial meningitis in adults. Surg Neurol 2005, 64:61–65.PubMedCrossRefGoogle Scholar
  17. 17.
    Diringer MN, Zazulia AR: Osmotic therapy: fact and fiction. Neurocrit Care 2004, 1:219–233.PubMedCrossRefGoogle Scholar
  18. 18.
    Ogden AT, Mayer SA, Connolly ES Jr: Hyperosmolar agents in neurosurgical practice: the evolving role of hypertonic saline. Neurosurgery 2005, 57:207–215.PubMedCrossRefGoogle Scholar
  19. 19.
    Diringer MN, Reaven NL, Funk SE, et al.: Elevated body temperature independently contributes to increased length of stay in neurologic intensive care unit patients. Crit Care Med 2004, 32:1489–1495.PubMedCrossRefGoogle Scholar
  20. 20.
    Angstwurm K, Reuss S, Freyer D, et al.: Induced hypothermia in experimental pneumococcal meningitis. J Cereb Blood Flow Metab 2000, 20:834–838.PubMedCrossRefGoogle Scholar
  21. 21.
    Schwab S, Junger E, Spranger M, et al.: Craniectomy: an aggressive approach in severe encephalitis. Neurology 1997, 48:412–417.PubMedGoogle Scholar
  22. 22.
    Cuthbertson BH, Dickson R, Mackenzie A: Intracranial pressure measurement, induced hypothermia and barbiturate coma in meningitis associated with intractable raised intracranial pressure. Anaesthesia 2004, 59:908–911.PubMedCrossRefGoogle Scholar
  23. 23.
    de Gans J, van de Beek D, European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators: Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002, 347:1549–1556.PubMedCrossRefGoogle Scholar
  24. 24.
    Kamei S, Sekizawa T, Shiota H, et al.: Evaluation of combination therapy using acyclovir and corticosteroids in adult patients with herpes simplex virus encephalitis. J Neurol Neurosurg Psychiatry 2005, 76:1544–1549.PubMedCrossRefGoogle Scholar
  25. 25.
    Meyding-Lamade UK, Oberlinner C, Rau PR, et al.: Experimental herpes simplex virus encephalitis: a combination therapy of acyclovir and glucocorticoids reduces long-term magnetic resonance imaging abnormalities. J Neurovirol 2003, 9:118–125.PubMedCrossRefGoogle Scholar
  26. 26.
    Thompson KA, Blessing WW, Wesselingh SL: Herpes simplex replication and dissemination is not increased by corticosteroid treatment in a rat model of focal herpes encephalitis. J Neurovirol 2000, 6:25–32.PubMedGoogle Scholar
  27. 27.
    van Crevel H, Hijdra A, de Gans J: Lumbar puncture and the risk of herniation: when should we first perform CT? J Neurol 2002, 249:129–137.PubMedCrossRefGoogle Scholar
  28. 28.
    Moller K, Larsen FS, Qvist J, et al.: Dependency of cerebral blood flow on mean arterial pressure in patients with acute bacterial meningitis. Crit Care Med 2000, 28:1027–1032.PubMedCrossRefGoogle Scholar
  29. 29.
    Pfister HW, Borasio GD, Dirnagl U, et al.: Cerebrovascular complications of bacterial meningitis in adults. Neurology 1992, 42:1497–1504.PubMedGoogle Scholar
  30. 30.
    Stam J: Thrombosis of the cerebral veins and sinuses. N Engl J Med 2005, 28:1791–1798.CrossRefGoogle Scholar
  31. 31.
    Weststrate W, Hijdra A, de Gans J: Brain infarcts in adults with bacterial meningitis. Lancet 1996, 347:399.PubMedCrossRefGoogle Scholar
  32. 32.
    Wang KW, Chang WN, Chang HW, et al.: The significance of seizures and other predictive factors during the acute illness for the long-term outcome after bacterial meningitis. Seizure 2005, 14:586–592.PubMedCrossRefGoogle Scholar
  33. 33.
    Solomon T: Flavivirus encephalitis. N Engl J Med 2004, 351:370–378.PubMedCrossRefGoogle Scholar
  34. 34.
    Bleck TP: Refractory status epilepticus. Curr Opin Crit Care 2005, 11:117–120.PubMedCrossRefGoogle Scholar
  35. 35.
    Holtkamp M, Othman J, Buchheim K, et al.: Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit. J Neurol Neurosurg Psychiatry 2005, 76:534–539.PubMedCrossRefGoogle Scholar
  36. 36.
    Claassen J, Mayer SA, Kowalski RG, et al.: Detection of electrographic seizures with continuous EEG monitoring in critically ill patients. Neurology 2004, 62:1743–1748.PubMedGoogle Scholar
  37. 37.
    Hamill JF, Bedford RF, Weaver DC, Colohan AR: Lidocaine before endotracheal intubation: intravenous or laryngotracheal? Anesthesiology 1981, 55:578–581.PubMedCrossRefGoogle Scholar
  38. 38.
    Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000, 342:1301–1308.Google Scholar
  39. 39.
    Coplin WM, Pierson DJ, Cooley KD, et al.: Implications of extubation delay in brain-injured patients meeting standard weaning criteria. Am J Respir Crit Care Med 2000, 161:1530–1536.PubMedGoogle Scholar
  40. 40.
    Vallverdu I, Calaf N, Subirana M, et al.: Clinical characteristics, respiratory functional parameters, and outcome of a two-hour T-piece trial in patients weaning from mechanical ventilation. Am J Respir Crit Care Med 1998, 158:1855–1862.PubMedGoogle Scholar
  41. 41.
    Rivers E, Nguyen B, Havstad S, et al.: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345:1368–1377.PubMedCrossRefGoogle Scholar
  42. 42.
    Oates-Whitehead RM, Maconochie I, Baumer H, Stewart ME: Fluid therapy for acute bacterial meningitis. Cochrane Database Syst Rev 2005, (3):CD004786.Google Scholar
  43. 43.
    Tureen JH, Tauber MG, Sande MA: Effect of hydration status on cerebral blood flow and cerebrospinal fluid lactic acidosis in rabbits with experimental meningitis. J Clin Invest 1992, 89:947–953.PubMedCrossRefGoogle Scholar
  44. 44.
    Richard C, Warszawski J, Anguel N, et al.: Early use of the pulmonary artery catheter and outcomes in patients with shock and acute respiratory distress syndrome: a randomized controlled trial. JAMA 2003, 290:2713–2720.PubMedCrossRefGoogle Scholar
  45. 45.
    Hollenberg SM, Ahrens TS, Annane D, et al.: Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med 2004, 32:1928–1948.PubMedCrossRefGoogle Scholar
  46. 46.
    Steiner LA, Johnston AJ, Czosnyka M, et al.: Direct comparison of cerebrovascular effects of norepinephrine and dopamine in head-injured patients. Crit Care Med 2004, 32:1049–1054.PubMedCrossRefGoogle Scholar
  47. 47.
    Annane D, Sebille V, Charpentier C, et al.: Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002, 288:862–871.PubMedCrossRefGoogle Scholar
  48. 48.
    Cronin L, Cook DJ, Carlet J, et al.: Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. Crit Care Med 1995, 23:1430–1439.PubMedCrossRefGoogle Scholar
  49. 49.
    van de Beek D, de Gans J: Dexamethasone and pneumococcal meningitis. Ann Intern Med 2004, 141:327.PubMedGoogle Scholar
  50. 50.
    van de Beek D, de Gans J, Tunkel AR, Wijdicks EF: Community-acquired bacterial meningitis in adults. N Engl J Med 2006, 354:44–53.PubMedCrossRefGoogle Scholar
  51. 51.
    Corticosteroid Therapy of Septic Shock—Corticus. http://www.clinicaltrials.gov/show/NCT00147004. Accessed April 11, 2007.
  52. 52.
    Bernard GR, Vincent JL, Laterre PF, et al.: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001, 344:699–709.PubMedCrossRefGoogle Scholar
  53. 53.
    Vincent JL, Nadel S, Kutsogiannis DJ, et al.: Drotrecogin alfa (activated) in patients with severe sepsis presenting with purpura fulminans, meningitis, or meningococcal disease: a retrospective analysis of patients enrolled in recent clinical studies. Crit Care 2005, 9:R331–R343.PubMedCrossRefGoogle Scholar

Copyright information

© Current Medicine Group LLC 2007

Authors and Affiliations

  1. 1.Department of NeurologyUniversity of VirginiaCharlottesvilleUSA

Personalised recommendations